Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-12 Sale |
2025-06-16 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
55,775 | $17.08 | $952,464 | 403,288 (Direct) |
View |
| 2025-06-03 Sale |
2025-06-05 5:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations |
6,206 | $17.02 | $105,628 | 58,576 (Direct) |
View |
| 2025-05-08 Sale |
2025-05-12 4:00 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" |
337,915 | $18.04 | $6,097,304 | 150,996 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
70,961 | $15.91 | $1,128,642 | 117,566 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:19 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial |
6,181 | $15.8 | $97,639 | 119,768 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:16 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer |
4,827 | $15.8 | $76,250 | 62,137 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:11 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
23,251 | $15.8 | $367,288 | 69,754 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:06 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
140,372 | $15.8 | $2,217,407 | 191,665 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
23,773 | $15.8 | $375,534 | 422,452 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:12 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
62,250 | $16.06 | $999,425 | 124,503 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
24,900 | $16.06 | $399,770 | 49,801 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-05 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
31,342 | $16.06 | $503,236 | 379,795 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-05 Option Award |
2025-06-09 4:25 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
14,492 | $0 | 88,189 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:25 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
9,632 | $0 | 88,189 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:22 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
14,492 | $0 | 73,264 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:22 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
9,632 | $0 | 73,264 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:20 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director |
14,492 | $0 | 36,996 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:20 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director |
9,632 | $0 | 36,996 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:18 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
14,492 | $0 | 112,401 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:18 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
9,632 | $0 | 112,401 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:15 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
14,492 | $0 | 119,807 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:15 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
9,632 | $0 | 119,807 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
14,492 | $0 | 130,149 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
9,632 | $0 | 130,149 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
14,492 | $0 | 2,118,455 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
9,632 | $0 | 2,118,455 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
14,492 | $0 | 127,739 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
9,632 | $0 | 127,739 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lichtenstein Chen Director |
14,492 | $0 | 14,492 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
21,739 | $0 | 448,011 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
17,158 | $0 | 448,011 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
14,492 | $0 | 814,807 (Direct) |
View |
| 2025-06-06 Exercise |
2025-06-09 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
9,632 | $0 | 814,807 (Direct) |
View |
| 2025-06-05 Option Award |
2025-06-09 4:01 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
52,173 | $0 | 52,173 (Direct) |
View |
| 2025-06-03 Exercise |
2025-06-05 5:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations |
16,195 | $0 | 58,576 (Direct) |
View |
| 2025-05-14 Option Award |
2025-05-19 4:00 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lippman Evan EVP, Business Development |
195,381 | $0 | 195,381 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:29 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
14,150 | $0 | 44,400 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 4:29 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
3,566 | $0 | 44,400 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:25 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial |
71,278 | $0 | 71,278 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:22 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer |
56,603 | $0 | 56,603 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
79,664 | $0 | 538,727 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 4:19 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
21,390 | $0 | 538,727 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:16 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
78,616 | $0 | 78,616 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" |
62,893 | $0 | 551,804 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" |
23,765 | $0 | 551,804 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations |
69,182 | $0 | 69,182 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" |
56,603 | $0 | 56,603 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
69,182 | $0 | 117,566 (Direct) |
View |
| 2025-03-05 Exercise |
2025-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
22,576 | $0 | 117,566 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
169,811 | $0 | 169,811 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:21 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
16,326 | $0 | 54,313 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:19 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial |
20,461 | $0 | 119,768 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:16 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer |
16,741 | $0 | 62,137 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
239,932 | $0 | 540,939 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
23,251 | $0 | 69,754 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" |
235,282 | $0 | 554,461 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
237,142 | $0 | 191,665 (Direct) |
View |
| 2025-03-04 Exercise |
2025-03-06 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
50,223 | $0 | 422,452 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:20 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
5,179 | $0 | 20,717 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:16 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" |
24,900 | $0 | 279,665 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
62,250 | $0 | 124,503 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
24,900 | $0 | 49,801 (Direct) |
View |
| 2025-03-03 Exercise |
2025-03-05 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
67,231 | $0 | 379,795 (Direct) |
View |